Silvia Schobesberger

Dr. Silvia Schobesberger

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2021 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
MRMario Rothbauer
Mario Rothbauer
RBRuth A. Byrne
Ruth A. Byrne
SSSilvia Schobesberger
Silvia Schobesberger
ICIsabel Olmos Calvo
Isabel Olmos Calvo
AFAnita Fischer
Anita Fischer
PEPeter Ertl
Peter Ertl
Rheumatoid arthritis is characterised by a progressive, intermittent inflammation at the synovial membrane, which ultimately leads to the destruction of the synovial joint. The synovial membrane as the joint capsule's inner layer is lined with fibroblast-like synoviocytes that are the key player supporting persistent arthritis leading to bone erosion and cartilage destruction. While microfluidic models that model molecular aspects of bone erosion between bone-derived cells and synoviocytes have been established, RA's synovial-chondral axis has not yet been realised using a microfluidic 3D model based on human patient in vitro cultures. Consequently, we established a chip-based three-dimensional tissue coculture model that simulates the reciprocal cross talk between individual synovial and chondral organoids. When co-cultivated with synovial organoids, we could demonstrate that chondral organoids induce a higher degree of cartilage physiology and architecture and show differential cytokine response compared to their respective monocultures highlighting the importance of reciprocal tissue-level cross talk in the modelling of arthritic diseases.

11 March 2025 in Lab on a Chip
Verified
Journal Article
Open access
KBKonstanze Brandauer
Konstanze Brandauer
SSSophie Schweinitzer
Sophie Schweinitzer
ALAlexandra Lorenz
Alexandra Lorenz
JKJudith Krauß
Judith Krauß
SSSilvia Schobesberger
Silvia Schobesberger
PEPeter Ertl
Peter Ertl
This review highlights current in vitro models as well as microfluidic dual- and multi-organ systems with a focus on absorption (skin, lung, gut) and metabolism (liver) studies.

9 April 2024 in Talanta
Verified
Journal Article
Closed access
SJStefan Jarić
Stefan Jarić
SSSilvia Schobesberger
Silvia Schobesberger
Lazar VelickiLazar Velicki
Lazar Velicki
AMAleksandra Milovancev
Aleksandra Milovancev
SNStanislava Nikolić
Stanislava Nikolić
Nikola KneževićNikola Knežević
Nikola Knežević

20 February 2025 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
KBKonstanze Brandauer
Konstanze Brandauer
ALAlexandra Lorenz
Alexandra Lorenz
SSSilvia Schobesberger
Silvia Schobesberger
PSPatrick Schuller
Patrick Schuller
MFMartin Frauenlob
Martin Frauenlob
PEPeter Ertl
Peter Ertl
A gut-on-a-chip platform with integrated gold electrodes has been developed to measure the barrier integrity of a human senescent model.

10 February 2024 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Open access
VSViktor Laurin Sedlmayr
Viktor Laurin Sedlmayr
SSSilvia Schobesberger
Silvia Schobesberger
SSSarah Spitz
Sarah Spitz
PEPeter Ertl
Peter Ertl
DWDavid J. Wurm
David J. Wurm
OSOliver Spadiut
Oliver Spadiut
Neutral and positively charged archaeal ether lipids (AEL) have been studied for their utilization as novel delivery systems for pDNA, showing efficient immune response with a strong memory effect while lacking noticeable toxicity. Recent technological advances placed mRNA lipid nanoparticles (LNPs) at the forefront of next-generation delivery systems; however, no study has examined AELs in mRNA delivery yet. In this study, we investigated either a crude lipid extract or the purified tetraether lipid caldarchaeol from Sulfolobus acidocaldarius as potential novel excipients for mRNA LNPs. Depending on their molar share in the respective LNP, particle uptake and mRNA expression levels could be increased by up to 10-fold in in vitro transfection experiments using both primary cell sources (HSMM) and established cell lines (Caco-2, C2C12) compared to a well-known reference formulation. This increased efficiency might be linked to a substantial effect on endosomal escape, indicating fusogenic and lyotropic features of AELs. This study shows the high value of archaeal ether lipids for mRNA delivery and provides a solid foundation for future in vivo experiments and further research.

4 October 2022 in Journal of Biotechnology
Verified
Journal Article
Open access
SKStefan Kittler
Stefan Kittler
JEJulian Ebner
Julian Ebner
MBMihail Besleaga
Mihail Besleaga
JLJohan Larsbrink
Johan Larsbrink
BDBarbara Darnhofer
Barbara Darnhofer
OSOliver Spadiut
Oliver Spadiut
Protein L (PpL) is a universal binding ligand that can be used for the detection and purification of antibodies and antibody fragments. Due to the unique interaction with immunoglobulin light chains, it differs from other affinity ligands, like protein A or G. However, due to its current higher market price, PpL is still scarce in applications. In this study, we investigated the recombinant production and purification of PpL and characterized the product in detail. We present a comprehensive roadmap for the production of the versatile protein PpL in E. coli.